Nautilus Biotechnology Inc (NAUT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NAUT | AZN | AMGN | GILD | BMY |
| Company | Nautilus Biotechnology Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 2.70 | 199.40 | 375.18 | 146.32 | 61.80 |
| High | 2.80 | 199.52 | 377.09 | 146.75 | 62.00 |
| Low | 2.68 | 197.56 | 369.50 | 144.02 | 60.73 |
| Latest | 2.65 | 198.65 | 371.68 | 145.07 | 61.50 |
| Change | +0.03 | -2.88 | -7.59 | -3.15 | -0.83 |
| % Change | +1.15% | -1.43% | -2.00% | -2.13% | -1.33% |
| Volume | 66,160 | 690,215 | 333,468 | 764,304 | 1,967,121 |
| 20-Day Average Volume | 222,561 | 2,322,034 | 2,692,474 | 7,520,250 | 13,213,533 |
| Previous Close | 2.62 | 201.53 | 379.27 | 148.22 | 62.33 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.46 | 202.12 | 376.33 | 150.10 | 60.95 |
| 20-Day Raw Stochastic | 68.75% | 44.58% | 38.23% | 11.27% | 58.02% |
| 20-Day Relative Strength | 59.33 | 52.02 | 55.42 | 52.57 | 58.13 |
| Weighted Alpha | +159.38 | +34.81 | +24.22 | +31.63 | +13.58 |
| Today's Opinion | 100% Buy | 88% Buy | 88% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 100% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 72% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +12.81% since 02/26/26 | -2.82% since 02/26/26 | -1.78% since 02/26/26 | +0.64% since 02/26/26 | -0.43% since 02/26/26 |
| Low | 2.17 on 03/02/26 | 197.10 on 03/03/26 | 370.63 on 03/05/26 | 143.37 on 02/27/26 | 60.43 on 03/03/26 |
| High | 2.80 on 03/05/26 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 1-Month | |||||
| %Chg | +35.15% since 02/05/26 | +5.91% since 02/05/26 | +1.30% since 02/05/26 | -3.13% since 02/05/26 | +2.21% since 02/05/26 |
| Low | 1.97 on 02/11/26 | 187.06 on 02/09/26 | 361.00 on 02/11/26 | 143.09 on 02/26/26 | 59.23 on 02/19/26 |
| High | 3.08 on 02/25/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +34.48% since 12/05/25 | +9.91% since 12/05/25 | +12.94% since 12/05/25 | +19.36% since 12/05/25 | +16.65% since 12/05/25 |
| Low | 1.75 on 01/16/26 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 50.33 on 12/10/25 |
| High | 3.08 on 02/25/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +313.01% since 09/05/25 | +21.32% since 09/05/25 | +31.36% since 09/05/25 | +25.76% since 09/05/25 | +29.05% since 09/05/25 |
| Low | 0.65 on 09/08/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 3.08 on 02/25/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 331,598 | 312,554,496 | 204,452,320 | 184,003,424 | 126,933,432 |
| Shares Outstanding, K | 126,564 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -59,000,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -13,780,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.45 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 10/27/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/05/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.03 | 17.25 | 18.14 | 9.95 |